North Downs Pharma Consultancy Limited in Billericay, CM12 0EQ

Description

Data updated on: 01-11-2023

2013 marks the launching of North Downs Pharma Consultancy Limited, the firm that is situated at Lakeview House, 4 Woodbrook Crescent in Billericay. That would make eleven years North Downs Pharma Consultancy has prospered on the British market, as the company was established on 2013-02-15. The firm Companies House Reg No. is 08404698 and the zip code is CM12 0EQ. The company's SIC and NACE codes are 70229 : Management consultancy activities other than financial management. February 28, 2023 is the last time the accounts were filed.

The info we posses describing this enterprise's executives indicates there are two directors: Mandy C. and Peter C. who were appointed to their positions on 2013-02-15.

Peter C. is the individual who controls this firm, owns over 3/4 of company shares and has 3/4 to full of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2014-02-28	2015-02-28	2016-02-29	2017-02-28	2018-02-28	2019-02-28	2020-02-29	2021-02-28	2022-02-28	2023-02-28
Currency
Net Worth	45 785	85 967	137 068

Balance Sheet
Cash Bank In Hand	61 253	104 558	144 808
Cash Bank On Hand			144 808	186 128	142 660	164 451	142 107	158 073	176 505	98 611
Current Assets	72 178	115 044	169 613	193 630	163 864	184 146	147 475	179 447	176 899	98 611
Debtors	10 925	10 486	24 805	7 502	21 204	19 695	5 368	21 374	393
Other Debtors			295	302	408	7 564	418	449	393
Property Plant Equipment			1 396	1 376	1 414	1 255	587	1 387	1 087	573
Tangible Fixed Assets	652	1 471	1 396

Capital & Reserves
Called Up Share Capital	100	100	100
Profit Loss Account Reserve	45 685	85 867	136 968
Shareholder Funds	45 785	85 967	137 068

Other Financial Data
Amount Specific Advance Or Credit Directors						7 164
Amount Specific Advance Or Credit Made In Period Directors						7 164
Amount Specific Advance Or Credit Repaid In Period Directors							7 164
Accumulated Depreciation Impairment Property Plant Equipment			1 466	2 110	2 293	3 117	3 785	4 816	5 333	5 847
Average Number Employees During Period				2	2	2	2	2	2	2
Balances Amounts Owed To Related Parties		3 570		6 546
Creditors			33 941	28 073	13 857	22 806	15 411	39 522	48 500	9 428
Creditors Due Within One Year	27 045	30 548	33 941
Disposals Decrease In Depreciation Impairment Property Plant Equipment				206	718
Disposals Property Plant Equipment				412	718
Increase From Depreciation Charge For Year Property Plant Equipment				850	901	824	668	1 031	517	514
Net Current Assets Liabilities	45 133	84 496	135 672	165 557	150 007	161 340	132 064	139 925	128 398	89 183
Nominal Value Allotted Share Capital			100	100	100	100
Number Shares Allotted	100	100	100
Number Shares Issued Fully Paid				100	100	100	100	100	100	100
Other Creditors			4 245	7 271	3 466	850	1 378	16 054	33 225	9 428
Other Taxation Social Security Payable			29 696	20 802	10 391	21 956	14 033	23 468	15 275
Par Value Share	1	1	1	1	1	1	1	1	1	1
Property Plant Equipment Gross Cost			2 862	3 486	3 707	4 372	4 372	6 203	6 420
Share Capital Allotted Called Up Paid	100	100	100
Tangible Fixed Assets Additions	868	1 369	625
Tangible Fixed Assets Cost Or Valuation	868	2 237	2 862
Tangible Fixed Assets Depreciation	216	766	1 466
Tangible Fixed Assets Depreciation Charged In Period	216	550	700
Total Additions Including From Business Combinations Property Plant Equipment				1 036	939	665		1 831	217
Total Assets Less Current Liabilities	45 785	85 967	137 068	166 933	151 421	162 595	132 651	141 312	129 485	89 756
Trade Debtors Trade Receivables			24 510	7 200	20 796	12 131	4 950	20 925

Company staff

Mandy C.

Role: Director

Appointed: 15 February 2013

Latest update: 3 February 2024

Peter C.

Role: Director

Appointed: 15 February 2013

Latest update: 3 February 2024

People with significant control

Peter C.

Notified on 6 April 2016

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

Accounts Documents

Account next due date	30 November 2024
Account last made up date	28 February 2023
Confirmation statement next due date	29 February 2024
Confirmation statement last made up date	15 February 2023

Annual Accounts 8 September 2014
Start Date For Period Covered By Report	15 February 2013
End Date For Period Covered By Report	28 February 2014
Date Approval Accounts	8 September 2014
Annual Accounts 21 July 2015
Start Date For Period Covered By Report	01 March 2014
End Date For Period Covered By Report	28 February 2015
Date Approval Accounts	21 July 2015
Annual Accounts 6 June 2016
Start Date For Period Covered By Report	01 March 2015
End Date For Period Covered By Report	29 February 2016
Date Approval Accounts	6 June 2016
Annual Accounts
Start Date For Period Covered By Report	01 March 2016
End Date For Period Covered By Report	28 February 2017
Annual Accounts
Start Date For Period Covered By Report	01 March 2017
End Date For Period Covered By Report	28 February 2018
Annual Accounts
Start Date For Period Covered By Report	01 March 2018
End Date For Period Covered By Report	28 February 2019
Annual Accounts
Start Date For Period Covered By Report	01 March 2019
End Date For Period Covered By Report	29 February 2020
Annual Accounts
Start Date For Period Covered By Report	01 March 2020
End Date For Period Covered By Report	28 February 2021
Annual Accounts
Start Date For Period Covered By Report	01 March 2021
End Date For Period Covered By Report	28 February 2022
Annual Accounts
Start Date For Period Covered By Report	01 March 2022
End Date For Period Covered By Report	28 February 2023

North Downs Pharma Consultancy Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Mandy C.

Peter C.

People with significant control

Peter C.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies